I am not one that would even know how to appraise this stock, but to say it is being sold as a shell, is a major understatement. This is a real product, that is selling well. The company is increasing sales on all levels. The company looking to buy it, can use the product. Wounds for diabetics are a big problem, and this product has a proven track record of helping them to heal, faster and cleaner.
This not definitely not a shell sale, this is a usable product that is being sold to a established company that can market it much better than the wound management company can.
News 
Market Data 
Discover 
